Prevalence of multidrug resistant and extended spectrum beta-lactamase producing Pseudomonas aeruginosa in a tertiary care hospital

Saudi Journal of Biological Sciences

Volumn 22, Issue 1, 2015, Pages 62-64

  Shaikh, Sibhghatulla ^a   Fatima, Jamale ^a   Shakil, Shazi ^a   Danish Rizvi, Syed Mohd ^a   Kamal, Mohammad Amjad ^b,c  

^a INTEGRAL UNIVERSITY   (India)

^b KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^c King Fahd Medical Research Center King Abdulaziz University ^*  (Australia)

Author keywords

Double disc synergy test; Extended spectrum beta lactamases; Imipenem; Meropenem; Pseudomonas aeruginosa

Indexed keywords

PSEUDOMONAS AERUGINOSA;

EID: 84919835622     PISSN: 1319562X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sjbs.2014.06.001     Document Type: Article

References (14)

1. Aggarwal R., Chaudhary U., Bala K. Detection of extended-spectrum β-lactamase in Pseudomonas aeruginosa. Indian J. Pathol. Microbiol. 2008, 51(2):222-224.
2. Bandekar N., Vinodkumar C.S., Basavarajappa K.G., Prabhakar P.J., Nagaraj P. Beta lactamases mediated resistance amongst gram negative bacilli in Burn Infection. Int. J. Biol. Med. Res. 2011, 2(3):766-770.
3. Begum S., Salam M.A., Alam K.F., Begum N., Hassan P., Haq J.A. Detection of extended spectrum β-lactamase in Pseudomonas spp. isolated from two tertiary care hospitals in Bangladesh. BMC Res. Notes 2013, 6:7.
4. Bradford P.A. Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 2001, 14:933-951.
5. Clinical and Laboratory Standards Institute: Performance Standards for Antimicrobial Susceptibility Testing: Eighteenth Informational Supplement. M100-S18. Wayne, PA, 2008.
6. Cowan S.F., Steel K.J. Manual for the Identification of the Medical Bacteria 1970, Cambridge University Press, Cambridge.
7. Dundar D., Otkun M. InVitro efficacy of synergistic antibiotic combinations in multidrug resistant pseudomonas aeruginosa strains. Yonsei Med. J. 2010, 51:111-116.
8. Jarlier V., Nicolas M.H., Fourneir G. Extended spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in Enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev. Infect. Dis. 1998, 10:867-878.
9. Khanfar H.S., Bindayna K.M., Senok A.C., Botta G.A. Extended spectrum beta-lactamases (ESBL) in E. coli and K. pneumoniae: trends in the hospital and community settings. J. Infect. Dev. Countries 2009, 3:295-299.
10. Manchanda V., Singh N.P. Occurrence and detection of AmpC beta-lactamases among Gram negative clinical isolates using a modified three-dimensional test at Guru Tegh Bahadur Hospital, Delhi. Indian J. Antimicrob. Chemother. 2008, 51:415-418.
11. Mendiratta D.K., Deotale V., Narang P. Metallo beta lactamase producing Pseudomonas aeruginosa in a hospital from rural area. Indian J. Med. Res. 2005, 121:701-703.
12. Okesola A.O., Oni A.A. Occurrence of extended-spectrum beta-lactamase-producing Pseudomonas aeruginosa. Res. J. Med. Sci. 2012, 6(3):93-96.
13. Pagani L., Mantengoli E., Migliavacca R., Nucleo E., Pollini S., Spalla M., Daturi R., Romero E., Rossolini G.M. Multifocal detection of multidrug-resistant Pseudomonas aeruginosa producing the PER-1 extended spectrum beta-lactamase in northern Italy. J. Clin. Microbiol. 2004, 39:1865-1870.
14. Shahid M., Malik A., Sheeba Multidrug resistant Pseudomonas aeruginosa strains harbouring R-plasmids and Amp C β-lactamases isolated from hospitalized burn patients in tertiary care hospital of North India. FEMS Lett. 2003, 228:181-186.